Company / Assets per Share
NOVAVAX INC Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$7.33
FY2025
5-year range
$7.33 / $36.32
FY2021-FY2025
Trend
-34.4%
vs FY2024
Sector context
#122 of 210
Health Care
What the data says
At $7.33, NOVAVAX INC's assets per share ranks #122 of 210 in the Health Care sector. Assets per Share has declined for 5 consecutive years, from $48.91 in FY2020 to $7.33 in FY2025.
Based on SEC 10-K filings.
7.33 in FY2025 with a 5-year CAGR of -31.6%.
Declined from $20.89 to $7.33 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -37.3%
- 5-Year CAGR
- -31.6%
- 10-Year CAGR
- -
Sector benchmark
#122 of 210 in Health CareTop 58% of 210This company $7.33 Sector average $296.79
▼
-97.5% below sector average
Key checks
Key Insights
- NOVAVAX INC's assets per share has declined for 5 consecutive years.
- In FY2025, assets per share decreased 34.4% year-over-year.
- Ranks #122 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.33 | -34.4% |
| FY2024 | $11.19 | -46.5% |
| FY2023 | $20.89 | -29.9% |
| FY2022 | $29.78 | -18.0% |
| FY2021 | $36.32 | -25.8% |
| FY2020 | $48.91 | +443.6% |
| FY2019 | $9.00 | +1298.4% |
| FY2018 | $0.64 | -42.3% |
| FY2017 | $1.12 | -23.6% |
| FY2016 | $1.46 | -9.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026